ArticleBreast cancer research : BCR2026

LMAN2 promotes breast cancer progression and deduces cell sensitivity to doxorubicin through stearoyl-CoA desaturase.

Changjiao Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.